Steven J. Greco, PhD, a respected leader in regenerative medicine from Pinehurst, TX, is the Founder and Chief Operating Officer of PranaX Corporation, a biomedical research company based in Houston. With a background in biological sciences from Cornell University and a PhD in Stem Cell Biology from Rutgers University, Greco has dedicated his career to advancing regenerative medicine. His research focuses on utilizing exosome biology to promote regenerative processes, with a particular interest in reversing damage to aging tissues and organs, which can improve both appearance and overall health in later years.
Greco’s path to success in regenerative medicine has been shaped by his extensive experience working with early-stage biotech companies. His involvement with these companies provided him with valuable insights into drug development, ultimately leading to the founding of PranaX. Before establishing PranaX in 2022, Greco co-founded Rejenevie Therapeutics and served as Chief Scientific Officer at Houston Healthspan Innovation Group. Both companies were later acquired as subsidiaries of PranaX, where Greco applies his expertise to explore new solutions for Alzheimer’s disease and other aging-related conditions, focusing on in vitro diagnostics and biomarker identification.
For over two decades, Steven has been unwavering in his commitment to advancing the field of stem cell biology. His work in regenerative and translational medicine has earned him recognition as a leader in the field. Beyond his research, Greco is dedicated to educating the next scientists. As the founder of the Stem Cell Education Society, he has worked to raise public awareness about stem cell applications and has delivered presentations to students, researchers, and industry professionals on the latest advancements in rejuvenation medicine.
Greco’s academic journey began at Cornell University, where he studied Biological Sciences with a concentration in Animal Physiology. This focus gave him a solid foundation in anatomy, physiology, and biology, which would later prove invaluable in his career. After completing his undergraduate studies, Greco pursued a Master's in Biomedical Sciences at Rutgers University, where his growing interest in the natural sciences led him to focus on the body’s ability to combat disease and injury.
In 2007, Steven obtained his PhD from Rutgers Graduate School of Biomedical Sciences in Stem Cell Biology. While there, he worked as a Research Associate and Administrative Liaison in the Rameshwar Lab, where groundbreaking research on stem cell biology was conducted. His role involved managing preclinical development of cell restoration technologies, and he contributed to a study investigating the interaction between breast cancer and mesenchymal stem cells in bone marrow.
Steven’s professional career began with Neurotez Inc., where he served as Vice President of Research and Development, focusing on drug discovery for Alzheimer’s disease. He later took on the role of Principal Scientist at the Cell Health Institute in Newark, NJ, where he developed proprietary technologies to restore aging blood stem cell function. His work with Rutgers University helped propel his research and development in stem cell biology.
Greco’s career continued to evolve as he co-founded Rejenevie Therapeutics, where he served as Director of Research and later as Chief Scientific Officer. His research at Rejenevie focused on approaches to restore function to the aging immune system. He also contributed to Houston Healthspan Innovation Group as Lead Research Analyst and Chief Scientific Officer. The work at Houston Healthspan has been instrumental in shaping new approaches to treating age-related diseases, focusing on stem cell isolation, regenerative therapies, and healing amplification solutions.
As the Founder and Chief Operating Officer of PranaX, Steven has taken his career to new heights. PranaX leverages stem cell and exosome therapies to rejuvenate damaged or aging tissues and organs. The company is committed to improving the quality of life and extending life expectancy by addressing various health issues associated with aging. Since founding PranaX in 2023, Steven has raised $20 million to support the company's research and development efforts.
Greco is a recognized innovator in his field, holding numerous patents on stem cell biology and regenerative medicine. He has authored several publications on Alzheimer’s disease and aging, further contributing to the scientific understanding of these issues. Throughout his career, Greco has been awarded multiple honors from the New Jersey Commission on Science and Technology for his scientific achievements.
Steven J. Greco’s unwavering dedication to regenerative medicine, his commitment to research, and his contributions to stem cell biology continue to shape the future of healthcare. Through his leadership at PranaX, he is advancing the science of rejuvenation medicine, offering new hope for those impacted by age-related health conditions. His work in regenerative and translational medicine will undoubtedly leave a lasting impact on the field for years.
